Clinical Roundup Novel drug combination shows promise in advanced HER2-negative breast cancer treatment February 16, 2024Vol.50 No.07
Clinical Roundup New immunotherapy for multiple myeloma proves in the lab to be more effective than CAR T treatment already in use February 16, 2024Vol.50 No.07
Clinical Roundup Patient-reported outcomes indicate improved physical function for complete responders in phase II/III bladder cancer study February 16, 2024Vol.50 No.07
Clinical Roundup Plant-based diet tied to improved sexual health during prostate cancer treatment February 16, 2024Vol.50 No.07
Clinical Roundup Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics February 16, 2024Vol.50 No.07
Clinical Roundup ACS CAN survey finds affordability is the leading policy priority for cancer patients and survivors February 16, 2024Vol.50 No.07
Clinical Roundup Subcutaneous Opdivo shows noninferiority vs. intravenous Opdivo in advanced or metastatic RCC February 02, 2024Vol.50 No.05
Clinical Roundup Global cancer burden grows amid mounting need for services February 02, 2024Vol.50 No.05
Clinical Roundup Anti-cancer compound goes beyond current BTK inhibitors in CLL, other blood cancers February 02, 2024Vol.50 No.05
